Related Experiment Video
Updated: May 1, 2026
07:50
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
2.0K
Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus
Mary E Hensler1, Kyoung Hwa Jang2, Wdee Thienphrapa1
1Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
The Journal of Antibiotics
|April 17, 2014
Summary
Anthracimycin, a marine compound, effectively kills various Staphylococcus aureus strains, including MRSA. This novel antibiotic shows promise for treating infections caused by resistant bacteria.
Area of Science:
- Marine natural products
- Antimicrobial drug discovery
- Bacterial pathogenesis
Background:
- Staphylococcus aureus, including methicillin-resistant strains (MRSA), poses a significant global health threat.
- Novel therapeutic agents are urgently needed to combat antibiotic-resistant bacterial infections.
Purpose of the Study:
- To evaluate the in vitro and in vivo efficacy of anthracimycin against Staphylococcus aureus.
- To investigate the mechanism of action and safety profile of anthracimycin.
Main Methods:
- Broth microdilution assays to determine minimum inhibitory concentrations (MICs).
- Time-kill assays to assess bactericidal activity against MRSA.
- Macromolecular synthesis assays to investigate mechanism of action.
- In vivo murine peritonitis model to evaluate therapeutic efficacy.
Main Results:
- Anthracimycin demonstrated potent activity against all tested S. aureus strains (MICs ⩽0.25 mg/L), including MRSA and vancomycin-resistant strains.
- Rapid and potent bactericidal activity was observed, with a >4-log kill of USA300 MRSA within 3 hours at 5x MIC.
- Anthracimycin inhibited nucleic acid synthesis in S. aureus without DNA intercalation.
- The compound protected mice from MRSA-induced mortality in a peritonitis model with minimal toxicity to human cells (IC50 = 70 mg/L).
Conclusions:
- Anthracimycin is a potent marine-derived compound with broad-spectrum activity against Staphylococcus aureus, including resistant strains.
- Its novel mechanism of action and efficacy in vivo suggest potential as a new scaffold for MRSA antibiotic development.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
01:25Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
01:28Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
01:25Inhibitors of Bacterial Protein Synthesis
106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
01:29Staphylococcal Skin Infections
143
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
01:31Defense Against Bacterial Pathogens
3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K